Home Supplements How We Rate Blog
Calcium

Calcium

Research reviewed: Up until 03/2026

Calcium is a dietary supplement with 3 published peer-reviewed studies involving 1,556 participants, researched for Bone Health, Blood Pressure.

3
Studies
1,556
Participants
1986–2006
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Bone Health

Strong
2 studies 1 of 2 positive 1,538 participants

Blood Pressure

Moderate
1 study 1 of 1 positive 18 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

3/3
Randomised
3/3
Double-Blind
3/3
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2006)
1,460
Study 2 (1995)
78
Study 1 (1986)
18

Research Timeline

When the studies were published

1
1986
1
1995
1
2006

All Studies

Detailed breakdown of each trial. Click to expand.

Bone Health

1

To assess the effects of calcium carbonate supplementation over 5 years on bone structure and clinical fracture incidence in elderly women

2006 1,460 participants 5 years 1,200 mg/day elemental calcium (as calcium carbonate) or pla...
Human Study RCT Double-Blind Placebo Positive

Study Type

Double-blind, placebo-controlled, randomised trial

Purpose

To assess the effects of calcium carbonate supplementation over 5 years on bone structure and clinical fracture incidence in elderly women

Dose

1,200 mg/day elemental calcium (as calcium carbonate) or placebo

Participants

1,460 elderly women aged β‰₯ 70 years

Duration

5 years

Results

Researchers observed that calcium supplementation significantly reduced the risk of all clinical fractures by 13% . Bone mineral density (an indicator of bone strength) at the hip was also significantly higher after 5 years in women taking calcium, with a difference of about 1–2%). In addition, cortical bone width at the tibia (the main lower leg bone; thicker bone means stronger structure) was significantly greater, suggesting calcium helped maintain bone strength and structure, reducing fracture risk over time.

Read full study
2

To determine whether oral calcium supplementation produces a sustained reduction in bone loss in healthy postmenopausal women with relatively low dietary calcium intake

1995 78 participants 4 years total (2-year extension of the original 2-year trial), with bone density measured every 6 months 1 g elemental calcium per day (oral tablets) or placebo, wit...
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled trial β€” extension of a 2-year RCT to 4 years

Purpose

To determine whether oral calcium supplementation produces a sustained reduction in bone loss in healthy postmenopausal women with relatively low dietary calcium intake

Dose

1 g elemental calcium per day (oral tablets) or placebo, with no change in usual diet

Participants

78 women who had completed an earlier 2-year double-blind trial; aged at least 3 years postmenopause at enrolment

Duration

4 years total (2-year extension of the original 2-year trial), with bone density measured every 6 months

Results

Researchers observed that total body bone mineral density (a measure of bone strength) showed a significant slowing of bone loss in the calcium group over the full 4-year period. Specifically, during years 2–4, bone loss was significantly reduced by 0.25% per year. However, there was no significant effect at specific sites like the lumbar spine (lower back bones) or proximal femur (upper thigh/hip area) in years 3–4, suggesting the benefit may vary depending on the part of the body.

Read full study

Blood Pressure

1

To determine whether oral calcium supplementation reduces blood pressure in patients with established essential hypertension

1986 18 participants 15 weeks per treatment period 1 g/day elemental calcium (oral supplement) or placebo
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled crossover trial

Purpose

To determine whether oral calcium supplementation reduces blood pressure in patients with established essential hypertension

Dose

1 g/day elemental calcium (oral supplement) or placebo

Participants

18 patients with uncomplicated essential hypertension (mild-to-moderate); no antihypertensive medication during the trial

Duration

15 weeks per treatment period

Results

Researchers observed that standing systolic blood pressure (SBPβ€”the top number in a blood pressure reading, showing pressure when the heart pumps; high levels increase risk of heart disease) was significantly reduced by βˆ’8.6 mmHg with calcium supplementation compared to placebo. The effect was stronger in people who had higher urinary calcium excretion (a measure of how much calcium is lost in urine, reflecting how the body handles calcium), with a strong inverse relationship, meaning those losing more calcium in urine had the biggest blood pressure improvements. This suggests calcium may be especially helpful for a specific group of people with this underlying calcium imbalance.

Read full study

Frequently Asked Questions

Common questions about Calcium research

What does the research say about Calcium?

There are currently 3 peer-reviewed studies on Calcium (Calcium), involving 1,556 total participants. Research covers Bone Health, Blood Pressure. The overall evidence strength is rated as Strong.

How strong is the evidence for Calcium?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (3 human studies), and reported outcomes.

What health goals has Calcium been studied for?

Calcium has been researched for: Bone Health, Blood Pressure. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Calcium based on human trials?

Yes, 3 out of 3 studies are human trials. Human trials carry more weight in our evidence scoring system.